Gürdal Sahin, MD, PhD, Specialist in Neurology and Head of the Skåneuro Private Headache and Movement Disorders Clinic, Institution for Clinical Sciences, Lund University. 
Social distancing during the Covid pandemic has limited clinicians’ ability to provide face-to-face care and disrupted the assessment, monitoring and supervision normally provided in outpatient clinics. Telemedicine is an option for providing care remotely that offers service continuity, with some success in the management of headache.1-3 Its uptake during the pandemic may foretell a wider role in the future (Figure 1).

References

1. Friedman DI, Rajan B, Seidmann A. A randomized trial of telemedicine for migraine management. Cephalalgia. 2019;39:1577-1585.
2. Müller KI, Alstadhaug KB, Bekkelund SI. Acceptability, feasibility, and cost of telemedicine for nonacute headaches: a randomized study comparing video and traditional consultations. J Med Internet Res. 2016;18:e140. doi: 10.2196/jmir.5221.
3. Müller KI, Alstadhaug KB, Bekkelund SI. Telemedicine in the management of non-acute headaches: a prospective, open-labelled non-inferiority, randomised clinical trial. Cephalalgia. 2017;37:855-863.
4. Landsness EC, Wang LH, Bucelli RC. Ziprasidone as a potential abortive therapy for status migrainosus. Neurohospitalist. 2016;6:151-156.
5. Dodick DW. CGRP ligand and receptor monoclonal antibodies for migraine prevention: evidence review and clinical implications. Cephalalgia. 2019;39:445-458.
6. Robblee J, Starling AJ, Halker Singh RB et al. Teleneurology for primary headache disorders. Practical Neurology 2020;June:31-9.